Verucerfont

CAS : 885220-61-1

Ref. 3D-KKB22061

Informations sur le produit

• Nom: Verucerfont
• Synonymes: Pyrazolo[1,5-a]pyrimidin-7-amine, 3-(4-methoxy-2-methylphenyl)-2,5-dimethyl-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]-, NBI 77860, 3-(4-Methoxy-2-methylphenyl)-2,5-dimethyl-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]pyrazolo[1,5-a]pyrimidin-7-amine, GSK 561679A

Description

Verucerfont is a drug that binds to the glucocorticoid receptor and inhibits transcription. It has been shown to have potent anti-inflammatory effects in mouse models of inflammatory diseases, such as arthritis and colitis, by inhibiting cytokine production. Verucerfont also potently inhibits the synthesis of proinflammatory cytokines in human cells, including IL-1β, IL-6, and TNFα. Verucerfont has not been shown to be effective for treating inflammatory diseases in women.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 406.48 g/mol
• Formule: C₂₂H₂₆N₆O₂
• Degré de pureté: Min. 95%